Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis

52Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

P2Y purine nucleotide receptors (P2YRs) promote endothelial cell tubulogenesis through breast cancer cell-secreted nucleoside diphosphate kinase (NDPK). We tested the hypothesis that activated P2Y 1 receptors transactivate vascular endothelial growth factor receptor (VEGFR-2) in angiogenic signaling. P2Y 1 R stimulation (10 M 2-methyl-thio-ATP (2MS-ATP)) of angiogenesis is suppressed by the VEGFR-2 tyrosine kinase inhibitor, SU1498 (1 M). Phosphorylation of VEGFR-2 by 0.0262 or 2.62 nM VEGF was comparable with 0.01 or 10 M 2MS-ATP stimulation of the P2Y 1 R. 2MS-ATP, and VEGF stimulation increased tyrosine phosphorylation at tyr1175. 2MS-ATP (0.1-10 M) also stimulated EC tubulogenesis in a dose-dependent manner. The addition of sub-maximal VEGF (70 pM) in the presence of increasing concentrations of 2MS-ATP yielded additive effects at 2MS-ATP concentrations 3 M, whereas producing saturated and less than additive effects at 3 M. We propose that the VEGF receptor can be activated in the absence of VEGF, and that the P2YR-VEGFR2 interaction and resulting signal transduction is a critical determinant of vascular homoeostasis and tumour-mediated angiogenesis.© 2009 Cancer Research UK.

Cite

CITATION STYLE

APA

Buxton, I. L. O., Rumjahn, S. M., Yokdang, N., Baldwin, K. A., & Thai, J. (2009). Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis. British Journal of Cancer, 100(9), 1465–1470. https://doi.org/10.1038/sj.bjc.6604998

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free